EcoR1 Capital’s Eikon Therapeutics EIKN Stock Holding History
Bought
Maintained
Sold
Other funds holding EIKN
EcoR1 Capital's EIKN Position: Q3 2026 in Review
EcoR1 Capital increased its Eikon Therapeutics (EIKN) stake by 17% in Q3 2026, buying an estimated $1.24M and bringing the position to 855,634 shares worth $6.88M. The position accounts for 0.31% of the portfolio, ranked #28.
EcoR1 Capital first reported a position in EIKN in Q1 2026 and has held it in 3 quarters since. The position peaked at $9.6M in Q2 2026. 98 funds tracked by Wall St. Rank hold EIKN as of Q3 2026.
- EcoR1 Capital held 855,634 shares of Eikon Therapeutics worth $6.88M as of Q3 2026.
- EcoR1 Capital bought 123,028 Eikon Therapeutics shares in Q3 2026, an estimated $1.24M.
- Eikon Therapeutics made up 0.31% of EcoR1 Capital's portfolio in Q3 2026, its #28 holding.
- EcoR1 Capital first reported a position in Eikon Therapeutics in Q1 2026 and has held it in 3 quarters since.
- EcoR1 Capital's Eikon Therapeutics position peaked at $9.6M in Q2 2026.
- 98 funds tracked by Wall St. Rank held Eikon Therapeutics as of Q3 2026.
Based on EcoR1 Capital's 13F filing for Q3 2026, filed 16 Nov 2026.